Mutations in the parkin gene are expected to play an essential role in autosomal recessive Parkinson's disease. Recent studies have established an impact of parkin mutations on mitochondrial function and autophagy. In primary skin fibroblasts from two patients affected by an early onset Parkinson's disease, we identified a hitherto unreported compound heterozygous mutation del exon2-3/del exon3 in the parkin gene, leading to the complete loss of the full-length protein. In both patients, but not in their heterozygous parental control, we observed severe ultrastructural abnormalities, mainly in mitochondria. This was associated with impaired energy metabolism, deregulated reactive oxygen species (ROS) production, resulting in lipid oxidation, and peroxisomal alteration. In view of the involvement of parkin in the mitochondrial quality control system, we have investigated upstream events in the organelles' biogenesis. The expression of the peroxisome proliferator-activated receptor gamma-coactivator 1-alpha (PGC-1α), a strong stimulator of mitochondrial biogenesis, was remarkably upregulated in both patients. However, the function of PGC-1α was blocked, as revealed by the lack of its downstream target gene induction. In conclusion, our data confirm the role of parkin in mitochondrial homeostasis and suggest a potential involvement of the PGC-1α pathway in the pathogenesis of Parkinson's disease. This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease.
Introduction
Parkinson's disease (PD) is a chronic progressive neurodegenerative movement disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra pars compacta.
While most cases of PD occur sporadically as the result of many different environmental factors, several gene products have been identified as responsible for Mendelian forms of PD. Autosomal dominant PD is caused by mutations in the leucine-rich repeat kinase 2 gene (LRRK2) [1] or in the α-synuclein gene [2] . The proteins implicated in autosomal recessive PD include parkin [3] , PTENinduced putative kinase 1 (PINK1) [4] , DJ-1 [5] and ATP13A2 [6] .
The evidence that these proteins are localized in mitochondria or are associated with the mitochondrial-dependent cell death would strengthen the hypothesis of mitochondrial oxidative dysfunction as the underlying alteration leading to PD development [7] . In particular, specific defects of complex I (CI) have been demonstrated in autoptic specimens from the frontal cortex, platelets, skeletal muscle and cell cybrids from PD patients [8] . Substantial evidence supports the hypothesis that oxidative stress plays a major role in PD pathogenesis [9, 10] conditions that, in dopaminergic neurons, could be amplified by the oxidative metabolism of dopamine [11] and the high levels of aerobic energy demand.
Since the discovery of mutations in the parkin gene (PARK2) as a cause of autosomal recessive juvenile parkinsonism [3] , almost half of all PD cases have been associated with mutations in this gene. Parkin is a multifunctional E3 ubiquitin ligase, which mediates ubiquitylation of several target proteins [12] . A link between parkin and mitochondria was originally suggested by the observation that parkin prevents cytochrome c release in ceramide-treated cells [13] . Several studies on parkin-null animal models strongly suggest an important role of the parkin gene for the preservation of mitochondrial function. Despite having only mild deficits, parkin knockout mice exhibit mitochondrial dysfunction and oxidative damage [14, 15] and Drosophila parkin null mutants display mitochondrial pathology and apoptotic muscle degeneration [16, 17] . Functional assays in leukocytes [18] as well as fibroblasts of patients with parkin mutations [19] [20] [21] consistently show mitochondrial impairment. Recently, increasing experimental evidence reveal that parkin interacts with PINK1 in a common pathway regulating mitochondrial dynamics [22] . Moreover, it can induce proteasome-independent ubiquitylation which serves for a remarkably wide range of physiological functions [23, 24] , such as membrane protein trafficking and autophagy [25] . Parkin is recruited to depolarized mitochondria, through direct phosphorylation by PINK1, to mediate their autophagic degradation [26] . Furthermore, parkin has emerged as an important factor in the mitochondrial quality control mechanisms [27] , where a fine balance of mitochondrial autophagy and biogenesis plays a key role in healthy mitochondrial network [28] . It has been reported that, in proliferating cells, parkin modulates basic mitochondrial functions and biogenesis through transcription/replication of mitochondrial DNA and protection of mitochondrial genomic integrity from oxidative stress [29] . A central role in a regulatory network involved in the transcriptional control of mitochondrial biogenesis and respiratory function is played by PGC-1α, a multifunctional protein found at higher levels in tissues with high metabolic requirement [30] . PGC-1α has emerged, in addition, as a key factor in the induction of many antioxidant programs in response to oxidative stress, in particular in neurons [31] . Several studies focus on the implication of PGC-1α in the pathogenesis of neurodegenerative diseases and open the possibility that modulation of PGC-1α activity could be of therapeutic interest in these disorders.
In the present study we have carried out a detailed genetic and biochemical analysis on primary skin fibroblasts from two sisters affected by an early onset PD, carrying mutations in parkin gene that cause a complete protein loss. Our analysis shows mitochondrial dysfunction associated with oxidative stress and altered PGC-1α function leading to transcription deregulation of target genes.
Materials and methods

Patients
We have examined an Italian family composed of four siblings, three of which show a juvenile form of PD. Diagnosis of PD was made according with the UK Brain Bank criteria: patients underwent neurological examination including the Unified Parkinson's Disease Rating Scale (UPDRS) and Hoen-Yahr Scale. The proband, a 36 year old man, showed an initial stiffness of the left leg at age 24 and over a few years, a camptocormic posture and a sporadic rest tremor of the left hand. At age 30, he had a moderate bradykinesia, symmetrical rigidity, a sporadic left hand rest tremor and a mild amimia. Cerebellar signs, a Babinski sign, supranuclear gaze palsy, autonomic involvement and/or cognitive deficit were absent (UPDRS scale 17). The two probands' female siblings that were analyzed are denominated P1 and P2 and the latter, twin sister of the proband, shows greater disease severity. Both siblings, first, showed a bradykinesia at age 35 (P1) and 31 (P2), followed, one year later, by a symmetrical rigidity and mild amimia. Cerebellar, pyramidal, oculomotoric, autonomic and cognitive dysfunction were absent (UPDRS scale 15 in P1 and 17 in P2 patients). Clinical response to dopaminergic treatment was excellent in the proband, while moderate in both sisters. The study was approved by the local Ethical Committee.
Genetic analysis of PD genes
After informed consent was obtained, total DNA was isolated from 3 ml peripheral blood with Iso Quick Nucleic Acid Extraction Kit (ORCA Research). The exons of PARK1 (α-synuclein), PARK2 (parkin), PARK6 (PINK1), PARK7 (DJ1) and PARK8 (LRRK2), were amplified by polymerase chain reaction (PCR). Primer pairs for amplification and sequencing have been previously described [2] [3] [4] [5] 32] . PCR reactions were purified using the ExoSAP-IT clean up method (Amersham Biosciences). Direct sequencing of both strands was done with Big Dye Terminator Cycle Sequencing Kit.
Reverse transcription (RT)-PCR and sequencing
Purification of total RNA from fibroblasts was carried out using RNeasy Mini Kit (Qiagen), according to the manufacturer's protocol. One microgram of total RNA was then reverse-transcribed to generate cDNA for PCR by using iScript cDNA Synthesis Kit (Bio-Rad). The parkin cDNA was amplified with the following PCR primers: sense 5′-TGGAGGATTTAACCCAGGAG-3′ and antisense 5′-ACAGGGCTTGGTG-GTTTTCT-3′. The PCR cycling protocol consisted of 30 cycles of denaturation at 94°C for 1 min, annealing at 55°C for 1 min and an extension at 72°C for 1 min. PCR products were gel purified using the QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer's instructions and then sequenced at PRIMM srl (Biomedical Science Park S. Raffaele, Milan, Italy).
Skin fibroblasts and culture conditions
Primary fibroblasts from the two siblings (P1, 36 years old, and P2, 32 years old) and the mother (parental healthy control, CTRL, 59 years old), were obtained by explants from skin punch biopsy, after informed consent. Control fibroblasts (NHDF AD, 56 years old) were purchased from American Type Culture Collection (ATCC; Virginia, USA). Cells were grown in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (v/v) L-glutamine, 1% (v/v) penicillin/streptomycin, at 37°C in a humidified atmosphere of 5% CO 2 . All experiments were performed on cells with similar passage numbers, ranging from 5 to 14, to avoid an artifact due to senescence, known to occur at passage numbers greater than 30. In the passage range used, fibroblasts were β-Gal negative [33] .
Where indicated, CTRL, P1 and P2 cells were grown in DMEM lacking glucose supplemented with 10% dialyzed FBS, 0.5 mg/l sodium pyruvate, 0.9 mg of galactose/ml.
Electron microscopy
Cells at 80% of confluence were collected by trypsinization and centrifugation, fixed in 3% glutaraldehyde, 0.1 M sodium phosphate buffer (pH 7.4) for 2 h, washed with the same buffer and subsequently fixed in 1% OsO 4 at 4°C. Next, cells were dehydrated in graded ethanol, and embedded in Epon 812. Ultrathin sections (60 nm) were cut with a diamond knife on a LKB-V ultratome, stained with uranyl acetate followed by lead citrate and examined under a Zeiss EM 109 electron microscope (Zeiss, Oberkochen, Germany). Digital images were obtained with a cooled camera Gatan CMS (Gatan GmbH, München, Germany) and analyzed using Adobe Photoshop software (Adobe Systems, Inc. San Jose, CA, USA).
Measurement of endogenous respiration rates in intact cells and substrate-supported respiration rates in digitonin-permeabilized cells
Mitochondrial oxygen consumption was measured polarographically with a Clark-type oxygen electrode in a water-jacketed chamber (Hansatech Instruments, Norfolk, UK), magnetically stirred at 37°C essentially as previously described [34, 35] .
For the measurement of respiration rates by endogenous substrates in intact cells, exponentially growing cells, fluid changed 1 day before the assays, were collected by trypsinization, and centrifugation and resuspended at 0.5-2 × 10 6 cells/ml in TD Buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 , 25 mM Tris-HCl, pH 7.4). Cell suspension was transferred to the polarographic chamber while an aliquot was used for cell counting and protein determination. After slope measurement, the coupled endogenous respiration was inhibited by 0.5 μg/ml oligomycin followed by 30 μM dinitrophenol (DNP). For the measurement of respiration rates by exogenous substrates in digitonin-permeabilized cells, after full uncoupling of the endogenous respiration of intact cells with 30 μM DNP, digitonin was added directly into the oxygraphic chamber at the optimal concentration of 30 μg/10 6 cells [36] . Since light microscopy of the cell monolayer revealed that patients' cells were larger than CTRL cells (data not shown) and that the specific cellular protein content was 2 and 3 fold higher in P1 and in P2, respectively, vs CTRL fibroblasts, all rates of oxygen consumption were normalized to cellular protein content [37] .
OXPHOS enzymes and citrate synthase activity measurements
Cells, collected by trypsinization and centrifugation, were resuspended in hypotonic medium (25 mM potassium phosphate, pH 7.2, 5 mM MgCl 2 ), supplemented with the antiprotease cocktail tablet (Roche, Basel, CH). In order to allow complete accessibility of substrates to the inner mitochondrial membrane enzymes, samples were freeze-thawed three times, gently shaken and then resuspended in the assay buffer. CI (NADH:ubiquinone oxidoreductase, rotenone sensitive), CII (succinate-CoQ oxidoreductase, malonate sensitive), CIV (cytochrome c oxidase, KCN sensitive) and citrate synthase activities were measured spectrophotometrically with a Beckman DU7400 equipped with a rapid-mixing apparatus at 30°C essentially as previously described [38] . ATP-hydrolase activity of Complex V (CV) (oligomycin sensitive) was measured on cell lysate as previously described [39] .
Oxidative phosphorylation capacity and cellular ATP level measurements
The rate of mitochondrial ATP synthesis was determined in digitonin-permeabilized fibroblasts, collected by trypsinization and centrifugation and resuspended at 0.5-2×10 6 
Lactate level and lactate dehydrogenase (LDH) activity measurements
Cells were seeded in 60 mm plastic Petri dishes and cultured for 48 h. The amount of lactate in the cell medium was estimated as described in [40] . LDH activity was measured spectrophotometrically on total cell lysates at 25°C by following NADH oxidation at 340 nm in 50 mM Tris-HCl pH 7.4, 2 μg/ml rotenone and 0.1 mM NADH. The assay was started by adding 5 mM pyruvate.
Mitochondrial and peroxisomal labeling and confocal microscopy
For mitochondrial network analysis the cells were stained with Quant-iT™ PicoGreen® dsDNA reagent (Invitrogen, Molecular Probes) and MitoTracker®Red CMXRos (Invitrogen, Molecular Probes). Transient transfections with pDsRed2-Peroxi (staining peroxisomes) and pEGFP-N1 (staining cytoplasm)/pEGFP-Mito (staining mitochondria) were performed using FuGENE®HD (Roche, Basel, CH) and TransIT®-LT1 (Mirus, Madison, USA) according to manufacturer's conditions. Living cells cultured for 2 days on glass bottom dishes (MatTek Corporation Ashland) were analyzed with the inverted confocal laser scanning microscope TCS SP5 (Leica Microsystems). To avoid a cross talk in excitation of multiple stained compounds a sequential scanning mode was used. Images were acquired with photo multipliers and micrographs were processed and analyzed with the software Leica Application Suite Advanced Fluorescence 2.0.0, Adobe Photoshop CS and Huygens Professional 3.4.0p1.
Real-time PCR
RTqPCR on cDNA were performed essentially as previously described [41] . Quantitative normalization of cDNA in each sample was performed using glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-actin and 18S rRNA as internal control. Validated primers for real-time PCR are reported in the Supplemental materials.
Intracellular ROS measurements
Intracellular ROS level was determined using the cell permeant probe 2′-7′dichlorodihydrofluorescin diacetate (H 2 DCFDA) [42] . Cells were incubated with 10 μM H 2 DCFDA in a serum free medium in the dark at 37°C for 30 min, collected by trypsinization, washed and resuspended in an assay buffer (100 mM potassium phosphate, pH 7.4, 2 mM MgCl 2 ). An aliquot was used for protein determination. The ROS-dependent oxidation of the fluorescent probe (507 nm excitation and 530 nm emission wavelength) was measured by a Jasco FP6200 spectrofluorimeter.
Antioxidant enzymes activities measurements
Measurements of antioxidant enzyme activities were carried out on cell lysates resuspended in hypotonic medium supplemented with the antiprotease cocktail tablet (Roche, Basel, CH), followed by a sonication step. Glutathione reductase, glutathione peroxidase (GPX) and catalase activities were assayed spectrophotometrically essentially as previously described [43] . Superoxide dismutase (SOD) activity was determined by using a native-gel activity-stain [44] . MnSOD was distinguished from cyanide-sensitive Cu/ZnSOD, by the addition of 2 mM KCN. Band intensity relative to the in-situ activity staining gels was calculated densitometrically using Quantity One-4.4.1 imaging software (Bio-Rad Laboratories). Silver staining of three replicate gel was used to verify equal loading.
Biochemical markers of oxidative stress
Cells, collected by trypsinization and centrifugation, were resuspended in hypotonic medium supplemented with the antiprotease cocktail tablet (Roche, Basel, CH) at a concentration of 1.5-2.0 mg protein/ml and homogenized with a glass/glass potter. Total glutathione (GSH), oxidized glutathione (GSSG) and protein sulfhydryl groups were measured as previously described [38] . For protein carbonyl (PC) determination, cellular proteins (1 mg) were precipitated with 10% TCA (w/v) and centrifuged. The pellet was resuspended in 1 ml of 0.2% (w/v) dinitrophenyl-hydrazine (DNPH) in 2N HCl or in 1 ml of 2N HCl, as a control blank, and processed [45] . The steady-state level of the lipid peroxidation product malondialdehyde (MDA) was assayed in cell lysates by determining thiobarbituric acid-reactive compounds (TBARs), spectrophotometrically at 532 nm [46] .
Western blot analysis
Total cell proteins (30 μg) were separated on a 13% Tris-Tricine SDS-PAGE according to [47] and transferred onto nitrocellulose membrane. Western blot analysis was performed using the specified primary antibodies against: CI-39 kDa subunit, CIII-Core 2 subunit, CIV-Cox IV subunit, CV-β subunit and porin (Invitrogen), catalase (Calbiochem), cyclic AMP-responsive element binding protein (CREB) and phosphorylated-CREB (P-CREB) (Santa Cruz Biotechnology) according to the manufacturer's suggested concentrations. Protein loading was assessed by reprobing the blots with β-actin (Sigma) or GAPDH (AbD Serotec) monoclonal antibodies. Proteins were detected by chemiluminescent LiteAblot reagent (Euroclone) and the signal was quantified by densitometric analysis using Quantity One-4.4.1 imaging software (Bio-Rad Laboratories). For the parkin western blot analysis, 40 μg whole cell lysate proteins were separated on a 4-12% Tris-Tricine SDS-PAGE. Monoclonal parkin primary antibody (Sigma) was used according to the manufacturer's suggested concentrations. For the PGC-1α western blot analysis, 60 μg whole cell lysate proteins resuspended in RIPA buffer (50 mM Tris, pH 7.5, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 0.1 % SDS, 0.5% Na-deoxycholate, protease inhibitor mixture (Roche, Basel, CH)) were separated on a 9% TrisGlycine SDS-PAGE. Polyclonal PGC-1 α primary antibody (Santa Cruz Biotechnology) was used according to the manufacturer's suggested concentrations.
Mitochondrial protein synthesis
Fibroblast cell cultures from CTRL, P1 and P2 patients, after a 16 h incubation with 50 μg/ml of chloramphenicol, were washed three times with PBS and then labeled with 30 μCi [ cysteine for 2 h, in the presence of 100 μg/ml of emetine, in methionine-free DMEM supplemented with 10% dialyzed FBS. The cells were collected by trypsinization and centrifugation, washed twice with TD buffer and then resuspended in 50 μl TD supplemented with the antiprotease cocktail tablet (Roche, Basel, CH). Proteins (60-70 μg) of cell suspensions were separated on a 14% Tris-Glycine SDS-PAGE. The gel was dried and analyzed by PhosphorImager (Bio-Rad). Protein loading was assessed by immunoblot analysis of equal amounts of proteins using β-actin monoclonal antibody.
Cyclic adenosine monophosphate (cAMP) assay
For cAMP assay, the culture medium was removed and 1 ml of 0.1 M HCl was added to the cell layer followed by 10 min incubation at 37°C. The lysed cells were scraped and transferred into Eppendorf tubes. The samples were centrifuged at 1300 ×g for 10 min at 4°C. The supernatants were used for cAMP measurement using a direct immunoassay kit (Assay Designs) according to the manufacturer's instruction.
Statistical analysis
Data are expressed as means ± SEM and statistically analyzed by the Student's t test.
Results
Mutation analysis
A first screening of coding sequences of the genes known to be associated with autosomal recessive PD (PARK2, PARK6, PARK7) and of genes associated with autosomal dominant PD (PARK1 and PARK8) did not reveal any alteration in both P1 and P2 patients (data not shown). Since standard genomic sequencing may fail to detect compound heterozygous deletional mutations, RT-PCR was used to characterize the parkin gene as previously described [48] . The expected RT-PCR product of 1355 bp was present in the parental control (CTRL) and in the commercially available NHDF AD control fibroblasts, but it was absent in both patients (Fig. 1A) . On the other hand, two bands, F1 (950 bp) and F2 (1191 bp) were detected in both patients, with the F1 being detectable also in the parental CTRL (Fig. 1A) . Direct sequencing of the F1 and F2 RT-PCR products revealed a deletion of exons 2-3 and exon 3, respectively. Therefore, both patients carry a compound heterozygous deletional mutation (del exon2-3/del exon3), while the unaffected parental control displays the heterozygous del exon2-3 (Fig. 1B) . The western blot analysis of parkin protein expression revealed the complete absence of the 50 kDa full-length protein in the fibroblasts of both patients and a comparable amount in CTRL fibroblasts and NHDF AD (Fig. 1C) .
Ultrastructural analysis of cultured fibroblasts
Electron microscopy was used to examine ultrastructural differences between CTRL, P1 and P2 fibroblasts. As shown in Figures 2 (A-C) , CTRL fibroblasts occur as elongated cells with thin plasma membrane filopodia, eucromatic nuclei and abundant rough endoplasmic reticulum (RER) with amorphous material filled cisternae. Numerous rounded or rod-like mitochondria normally arranged, with both lamellar and tubular cristae, lysosomal vacuoles and peroxisome-like bodies with uniform and moderately electron dense matrix were also scattered in the CTRL cytoplasm. Fibroblasts from both P1 and P2 patients (D-R) showed severe ultrastructural alterations, without morphological differences between each other, characterized by an irregular cellular shape with pseudopodia membranes and cytoplasmic protrusions, and heterochromatic and indented nuclei (Fig. 2D) . Cytoplasm appeared electron lucent with abnormal enlargements of the cisternae of rough reticulum (Fig. 2O ) and with numerous vesicles and lysosomal vacuoles completely (Figs. 2E,G,I arrow) or partially filled with electron dense material, possibly representing degenerating mitochondria (Figs. 2E,H,Q, arrowhead) , and often merging with RER cisternae (Figs. 2F,G, arrow) . Lamellaries bodies (Fig. 2N, arrow) , and peroxisome-like vacuoles, with a dense granular core (Figs. 2I,M asterisk), enveloped by lamellar structures (Fig. 2M, arrow) , or irregularly patched dense matrix (Fig. 2L) , were also detected. The most prominent abnormality, however, was represented by swollen mitochondria with few remaining cristae and decreased electron matrix density (Figs. 2O,P arrowhead) and degenerating with obscuration of the cristae and electron-dense matrices (residual bodies) (Figs. 2H,O,R, arrow) close to autophagic vacuoles containing mitochondrial membranes (Figs. 2Q,R, red arrow) . No abnormal mitochondrial structures were present in CTRL fibroblasts.
In order to obtain further insights into the observed morphological mitochondrial defects, the mitochondrial networks of cultured cells were stained with MitoTracker CMXRos and a noticeably more fragmented mitochondrial network was exhibited by patients' fibroblasts in respect to CTRL (Fig. 3) .
Functional analysis of bioenergetic metabolism
Next, we raised the question whether the marked changes in mitochondrial morphology may reflect alterations in mitochondrial function. The fibroblasts' competence for mitochondrial OXPHOS was first screened by monitoring cell growth rate in DMEM and in a selective medium containing galactose [49] . In high glucose-medium, patient's fibroblasts displayed a growth rate significantly lower with respect to the CTRL (Fig. 4A) . However, while the growth curves of CTRL cells in glucose and galactose medium were superimposable, those of patients' fibroblasts showed a marked difference. In fact, the growth rate of P1 and, even more, of P2 fibroblasts was dramatically impaired in the galactose medium that forced the cells to use predominantly oxidative phosphorylation system (OXPHOS) for ATP synthesis, as compared with glucose medium (Fig. 4A) . The mitochondrial respiratory function was then analyzed by measuring the oxygen consumption rates by endogenous substrates in intact cells. As shown in Figure 4B , the basal endogenous respiration rate in intact cells was significantly lower in P1 and P2 patients (47 ± 4.5% and 58 ± 3.9%, respectively) with respect to the CTRL fibroblast. Similarly, the maximal DNP-uncoupled respiration rates in P1 and P2 fibroblasts decreased by 56 ± 6.3% and 65 ± 2.5%, respectively, as compared with the CTRL value. In view of the marked age-related decline of fundamental processes essential for mitochondrial biogenesis and function in human fibroblasts [35] , it should be stressed that the respiratory rates of both control cells (CTRL and NHDF AD cells) fall within the range of their age matched group. Furthermore, the ratio of the DNP-uncoupled vs the oligomycin-blocked respiration rate (data not shown), was lower in both patients' as compared with CTRL cells, suggesting a certain degree of uncoupling in both patients.
To further dissect the observed decrease in endogenous respiration, we measured the maximal (uncoupled) respiratory fluxes by exogenous substrates supplying electrons to CI (glutamate + malate), CII (succinate) or CIV (ascorbate + TMPD) in digitonin-permeabilized cells (Fig. 4C) . A significant reduction of the uncoupled respiration rates was observed in both patients, independent of the substrate used, suggesting an overall reduction in the respiratory capacity of the electron transport chain. Respiratory fluxes were markedly decreased with respect to CTRL, by 41 ± 8.2%, 31 ± 6.5% and 25 ± 9.5% in P1, by 59 ± 3.3%, 50 ± 3.7% and 44 ± 4.3% in P2 using glutamate + malate, succinate and ascorbate + TMPD, respectively.
In order to investigate whether the observed decline of the respiratory fluxes in the patients was related to the impaired function of specific respiratory complexes, CI, CII and CIV activities were measured. As shown in Table 1 , a highly significant decrease of CI activity in P1 (36.1 ± 7.1%) and P2 (28.4 ± 3.7%) and, although to a smaller extent, of CIV in P1 (10.2 ± 5.5%) and P2 (18.3 ± 8.3%) as compared to the CTRL ones, was found. On the other hand, the CII activity was not significantly changed in patients' cells vs CTRL. Interestingly, the activity of citrate synthase, a well-known functional marker of mitochondrial content, was also decreased by 44 ± 4.5% and 38 ± 5.5% in P1 and P2, respectively, as compared to CTRL.
The OXPHOS capacity of both patients' fibroblasts was also examined by measuring the coupled state III respiration rate (in the presence of ADP) and cellular ATP production rate in permeabilized cells. Consistent with the results described above, we observed lower respiration rates in P1 and P2 fibroblasts with NAD-dependent substrates and with succinate as compared with the control values (Fig. 4D) . The oligomycin-sensitive ATP synthesis rates sustained by glutamate + malate and succinate were decreased by 51 ± 7.8% and 59 ± 5.9% in P1 and by 80 ± 3.3% and 71 ± 5.2% in P2, respectively as compared with CTRL cells (Fig. 4E) . Moreover, the oligomycinsensitive ATP hydrolase activity of CV also revealed a noteworthy decrease in both patients as compared to the CTRL value (data not shown).
Despite a defective OXPHOS, the cellular total ATP content, measured under basal conditions, was significantly higher in P1 (24 ± 9.2%) and in P2 (65 ± 5.6%) compared with CTRL values (Fig. 4F) . Similar results were obtained by measuring the ATP content under strict glycolytic conditions, i.e. in the presence of antimycin A and rotenone (data not shown). On the other hand, cellular ATP content, in the presence of the glycolytic inhibitor iodoacetic acid, was decreased by 44 ± 1.04% and 40± 1.39% in P1 and P2 fibroblasts, respectively (Fig. 4F) . These data indicate that the defective ATP production by OXPHOS in patients' fibroblasts is compensated by an increased glycolytic supply. Consistent with the increased glycolytic ATP production was the greater intracellular LDH activity (Fig. 4G ) observed in P1 (71.3 ± 13.8 %) and in P2 (84.1 ± 12.9%) as compared with CTRL, as well as the higher extracellular lactate levels (Fig. 4H) which were increased by 33 ± 9.4% and 52 ± 12.1% in P1 and P2 fibroblasts, respectively, as compared with CTRL fibroblasts. 
Oxidative stress analysis
Mitochondrial dysfunction is often associated with an increased ROS production, therefore we have evaluated the production of ROS by measuring the oxidation of H 2 DCFDA in patients and CTRL cells. As shown in Figure 5A , a significant increase in ROS production by 31 ± 9.9% and 53 ± 13.8% in P1 and P2 cells, respectively, was observed as compared with CTRL ones.
These results prompted us to investigate levels of oxidative stress markers. The content of protein carbonyls and TBARs, as protein and lipid oxidative damage markers, respectively, are shown in Figures 5B and C. When compared with CTRL, the total level of protein carbonyl did not differ significantly in PD patients' fibroblasts (Fig. 5B) , whereas higher TBARs were detected in P1 (52.6 ± 8.3%) and P2 (47.4 ± 5.9%) (Fig. 5C ). No significant difference was observed in the cellular content of GSH, GSSG and protein sulfhydryl groups (data not shown).
The differences in the ROS levels observed in the patients' cells could be also due to deficiencies in the scavenging apparatus. For these reasons, the activity of the antioxidant enzymes was analyzed. Fibroblasts of both patients exhibited a decreased activity of mitochondrial MnSOD (Fig. 5D ) (31.6± 4.7% in P1, 44.4 ± 13.6% in P2), GPX (Fig. 5E ) (30.9 ± 9.9% in P1, 54.5 ± 4.2% in P2) and catalase ( Fig. 5F ) (53.2 ± 5.7% in P1, 31.9 ± 4.8% in P2) compared to CTRL cells. No significant change in glutathione reductase activity was observed (data not shown). As shown in Figure 5G , the reduction of the catalase activity was due to a lower protein level which was decreased by 52.9 ± 4.7% and 53.1 ± 9.2% in P1 and P2, respectively, as compared to CTRL fibroblasts.
Finally, to test whether the decrease of catalase could be associated with a decreased peroxisome content, total peroxisome volume quantification was analyzed. The analysis revealed, unexpectedly, that P1 and P2 fibroblasts contain about a 5-6 fold increase of peroxisome volume (normalized to cell volume) when compared to CTRL (Fig. 6 ).
Mitochondrial biogenesis and PGC-1α dysfunction
To assess whether an altered expression of mitochondrial proteins could underlie the reduction in the respiratory chain complex activities observed in both patients, we evaluated, by semi-quantitative western blotting analysis, the steady-state levels of different OXPHOS subunits (Fig. 7A) . The results showed a significant decrease in the expression level of CI, CIII, CIV and CV subunits as well as of the mitochondrial outer membrane porin, in patients' fibroblasts with respect to the CTRL cells. The synthesis of mitochondrial-encoded proteins, measured by the incorporation of [ 35 S]-labeled methionine, appeared consistently decreased in P1 and P2 fibroblasts with respect to the CTRL (Fig. 7B) . Mitochondrial dysfunction often elicits a compensatory increase in organelle biogenesis. PGC-1α is a transcriptional coactivator directly involved in the upstream control of mitochondrial biogenesis [50, 51] . Several signal transduction pathways have been implicated in the control of PGC-1α expression and activity, among which is the cAMP mediated signal transduction pathways that results in phosphorylation of CREB [51] . Interestingly, we found a rise in the cAMP basal level (Fig. 7C) , associated with an increase of P-CREB in respect to total CREB content in both patients, more marked in P2 (151.5 ± 44.7%) than in P1 (32.2 ± 12.2%) as compared to CTRL fibroblasts (Fig. 7D) . In agreement with the results described above, PGC-1α expression appeared to be upregulated (Figs. 7E and F) . The endogenous PGC-1α transcripts were 5.8-fold and 12.6-fold higher in P1 and P2 respectively, compared to CTRL (Fig. 7E) . Consistently, the PGC-1α protein content was increased by 23.9 ± 7.4% in P1 and 85.5 ± 3.6% in P2 as compared with CTRL (Fig. 7F) . Strikingly, the mRNA levels of PGC-1α downstream target genes, directly involved in mitochondrial biogenesis (NRF1, NRF2, TFAM, ATPaseβ, COX II), as well as, in fatty acid metabolism (MCAD), resulted to be generally unchanged or even significantly lower in both patients as compared with CTRL (Fig. 7G) . The PGC-1α target genes for the antioxidant enzymes, GPX1 and SOD2, had likewise a significant lower expression (Fig. 7G) . Comparable patterns for mRNA levels of PGC-1α and its target genes were obtained by using β-actin (Fig. 7G) and GAPDH or 18S rRNA (Fig. S1) as housekeeping genes.
Discussion
Recent research on PD-associated genes has provided a fundamental knowledge of biochemical pathways associated with the disease process. Moreover, genetic and toxin models suggest that mitochondrial dysfunction is a common denominator of sporadic and familial PD. In the present work, we have carried out an extensive analysis of mitochondrial bioenergetic properties of fibroblasts from two siblings with juvenile PD. The genetic analysis revealed a hitherto unreported compound heterozygous mutation del exon2-3/del exon3 in the parkin gene, leading to the complete loss of the full-length protein. The del ex2-3 mutation was harbored in heterozygosis in the patients' mother who did not present any pathological symptom (parental healthy control, CTRL). Although exon2-3 [52] and exon3 [53] deletional mutations in the parkin gene have been previously described, this is, to our knowledge, the first report of the two mutations appearing simultaneously in compound heterozygotes.
Whether heterozygous mutations in the parkin gene can cause parkinsonism or can confer an increased susceptibility for typical late-onset PD is still controversial [54] [55] [56] [57] . The absence of any mitochondrial defect in the heterozygous parental control is in line with the evidence that the siRNA-mediated parkin 50% knockdown does not result in an impaired mitochondrial transmembrane potential nor in mitochondrial morphology alteration [20] . Mitochondrial defect has been primarily demonstrated by a specific impairment in growth of both patients' cells in a medium containing galactose, which is metabolized through the glycolytic pathway only very slowly [49] .
The mitochondrial functions investigated in CTRL exhibited unchanged values with respect to the unrelated matched control. We provide evidence, in PD patients' fibroblasts, of significantly decreased respiratory capacities by endogenous and exogenous substrates in intact and permeabilized cells, respectively, as compared with the parental control, and even more with the average agematched values (cf. [35] ). The more evident decline of the maximal respiratory rates by NAD-dependent substrates and of the specific CI enzyme activity is in agreement with previous data obtained in peripheral cells from parkin patients [18] and in mouse parkin mutants model [14] .
The inhibition of respiratory fluxes is also associated with a decline in CIV function as measured polarographically in intact (data not shown) and in digitonin-permeabilized cells and confirmed by the spectrophotometric assay of the specific CIV enzyme activity. A reduced capacity of the electron transport chain has been already reported in mouse models of PD, such as parkin − / − mice [14, 15] and [58] as well as in fibroblasts derived from patients bearing parkin mutations [20] . The functional decline could be due to the decreased protein level of OXPHOS subunits reported in our work and also described in parkin − / − mice by Palacino et al. [14] . These results would highlight the involvement of parkin in the biogenesis of mitochondrial respiratory chain complexes [59] .
The major harmful consequence of a defective electron transfer chain is displayed in ATP synthesis by OXPHOS. The decreased mitochondrial ATP synthesis by CI-and CII-substrates, observed in patients' fibroblasts, is compensated by an increase in the anaerobic glycolytic pathway. A general shift to anaerobic glycolysis in the neocortex of PD patients has been established by magnetic resonance spectroscopy and 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography studies, showing increased lactate concentrations [60] . As expected, the defects in the electron transfer chain lead to an increase in ROS production. The resulting significant increase in TBARs detected in the patients' fibroblasts, strengthen the role of lipid peroxidation as the major link between parkin fibroblasts and PD substantia nigra [61] . Lipid peroxidation products are thought to be markers of early PD pathogenesis even before clinical manifestation, since abnormally high levels have been observed in brain autopsies of asymptomatic individuals [62] and in the substantia nigra of PD patients [63] . On the contrary, no oxidative protein damage and no change in cellular glutathione content was detected in patients' cells, suggesting their possible implication in a later phase of PD pathogenetic mechanisms (see however [64, 65] ). Finally, the observation of the significant decline of catalase, glutathione peroxidase and MnSOD activities in the patients' fibroblasts worsen the oxidative stress condition that is considered a common underlying feature in PD pathogenesis (see also [66, 67] ). The brain is particularly vulnerable to oxidative stress since the high demand of a strictly aerobic energy production seems not to be balanced by an efficient antioxidant defense system as compared with other organs [68] . This scenario would become particularly dangerous in dopaminergic neurons where a pro-oxidant environment exists, due to the presence of dopamine. While the "vicious circle" between mitochondrial respiratory dysfunction and ROS production might be, somehow, expected, the decrease in the ROS scavenging system shifted our investigation in different directions. Of particular interest was, for us, the decrease of catalase activity and protein expression, and the increase in peroxisomal number observed in PD fibroblasts. Catalase exists primarily within peroxisomes and removes the H 2 O 2 generated by the long-chain fatty acid beta-oxidation pathway. The enzyme deficiency might contribute to the imbalance of intracellular ROS, affecting lipid metabolism and membrane function. Furthermore, the peroxisomal generated H 2 O 2 may move into the cytoplasm to induce an overall intracellular stress condition affecting organelles' function.
Recently, a close association between mitochondria and peroxisomes has been described [69] . Both organelles are in close contact with the endoplasmic reticulum, exchanging metabolites and sharing some metabolic pathways and components of their division machinery, so that their biogenesis can occur in a coordinated manner [69, 70] . The interrelationship between the two organelles has been strengthened by the recent demonstration of a concerted action of PGC-1α on mitochondrial function and peroxisomal specialization and biogenesis [71] . Indeed, it has been shown that the increase of the peroxisomal catalase level in senescent human cells restores mitochondrial integrity [72] while its inactivation results in mitochondrial dysfunction and an increase in peroxisome number [73] . Alterations in peroxisomal metabolism, biogenesis, dynamics and proliferation can potentially influence mitochondrial functions and vice versa having a negative impact on their cooperative function, thus contributing to disease appearance [69] and aging process [74] .
The morphological abnormalities that we observed in PD patients, mainly in mitochondria, would be the result of the mitochondrial dysfunctions and the oxidative stress condition so far described. In fact, current data suggest that parkin is required for the turnover of compromised mitochondria by promoting their autophagy [26, 75, 76] , recruiting the autophagic adaptor protein p62 [77, 78] , a protein involved, also, in pexophagy [79] . The imbalance between the extent of autophagy induction and the ability of the cell to complete autophagic degradation and recycling/regeneration of cellular components, upregulating compensatory biosynthetic responses, would create a state of autophagic stress and eventually cell death [80] .
In this scenario and in the light of the possible involvement of parkin in mitochondrial turnover [59] , we have investigated upstream events in the organelles biogenesis. Several signal transduction pathways are implicated in the control of expression and activity of PGC-1α, a strong regulator of mitochondrial biogenesis, required, as well, for the induction of many ROS detoxifying enzymes upon oxidative stress [31] . Activation of the cAMP signaling pathway is a major mechanism underlying the induction of PGC-1α, whose promoter contains a functional CREB binding site that is required for cAMP response [51] . Abnormal PGC-1α activity likely plays an important role in the pathogenesis of several metabolic diseases [51] and it is rising its involvement in the pathogenesis of neurodegenerative disorder such as Huntington's disease [81, 82] and Friedreich's ataxia [83] . Specifically related to PD is the evidence that a PGC-1α knockout mice shows enhanced susceptibility to neuronal loss following MPTP exposure [31] . Furthermore, during the preparation of this manuscript, Scherzer's group reported a reduced expression of PGC-1α target genes related to mitochondrial function and energy production, in the substantia nigra and in non-nigral tissues of PD patients [84] .
In our study, changes in cellular metabolism, due to the loss of mitochondrial oxidative capacity, could elicit an adaptive response by promoting a signaling pathway involving activation of CREB by phosphorylation, which is reported to be catalyzed by several kinases such as the cAMP-dependent Protein Kinase (PKA) [30] . CREB phosphorylation leads to the remarkable upregulation of PGC-1α expression which is, however, not associated with any increase in the transcript levels of its target genes. This fact would pinpoint to possible post-translational modifications known to modulate PGC-1α function such as phosphorylation, acetylation, methylation and sumoylation [85] . These modifications can affect the intrinsic activity and stability of PGC-1α or regulate its interaction with other proteins. In particular, the reversible acetylation by the NAD-dependent protein deacetylase sirtuin 1 (SIRT1) is emerging as a crucial controller of mitochondrial biogenesis [86] and autophagy [87] .
Conclusion
In conclusion, this work strengthens the role of mitochondrial dysfunctions and oxidative stress in PD pathogenesis, highlighting the overall mitochondrial homeostasis impairment as causative of the pathological process. The compensatory increase of PGC-1α level is not associated with induction of its target genes thus failing to correct the mitochondrial defects as well as the oxidative stress condition. Involvement of PGC-1α in parkin-associated PD still require further studies routed to define the role of parkin in quality control of mitochondria and peroxisomes. Strategies to promote PGC-1α function could represent a promising therapeutic approach for the treatments of multiple forms of PD and other neurodegenerative disorders.
Supplementary materials related to this article can be found online at doi:10.1016/j.bbadis.2010.12.022.
